MNK (MNK) News
Follow MNK (MNK) news in one place: company catalysts, earnings, analyst actions and wider market developments. Review 4 public stories across 4 publication days to understand how the story developed. Public news appears after a 15-minute delay; LiveCast subscribers can follow new headlines and hear important updates without this additional delay.
L
MNK - Keenova Marks the 2nd Annual National Hand Health Month with New Dupuytren's Contracture Mixed Reality Experience and Awareness Initia
MNK - Keenova Marks the 2nd Annual National Hand Health Month with New Dupuytren's Contracture Mixed Reality Experience and Awareness Initiatives
EQUITY | Sep 01, 2026, 11:30 AM UTC
M
Keenova doses first patient in Phase 3 XIAFLEX hammer toe trial
MNK’s Keenova advances its podiatry pipeline by dosing the first patient in a Phase 3 trial of XIAFLEX (collagenase clostridium histolyticum) for hammer toe.
EQUITY | Aug 20, 2026, 11:30 AM UTC
M
MNK Publishes XIAFLEX Manuscript
MNK publishes XIAFLEX study results
EQUITY | Aug 03, 2026, 11:30 AM UTC
L
MNK - Keenova Therapeutics to Report Second Quarter 2026 Financial Results on August 11, 2026
MNK - Keenova Therapeutics to Report Second Quarter 2026 Financial Results on August 11, 2026
EARNINGS | Jul 30, 2026, 11:00 AM UTC